Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.75%30.78M | 15.43%30.05M | 3.23%108.06M | -4.76%24.12M | -2.13%28.8M | 4.40%29.11M | 18.06%26.04M | 22.28%104.68M | 16.06%25.32M | 42.71%29.43M |
| Cost of revenue | 5.68%20.23M | 8.75%19.37M | -1.26%72.18M | -6.58%15.82M | -6.90%19.13M | -2.63%19.14M | 11.60%17.81M | 15.89%73.1M | 6.64%16.93M | 34.40%20.55M |
| Gross profit | 5.87%10.56M | 29.89%10.69M | 13.61%35.89M | -1.09%8.3M | 8.91%9.67M | 21.22%9.97M | 34.96%8.23M | 40.17%31.59M | 41.29%8.39M | 66.53%8.88M |
| Operating expense | 10.00%5.86M | 26.69%7.06M | 13.90%23.15M | 6.81%7M | 16.39%5.1M | 12.85%5.33M | 27.10%5.57M | 9.95%20.32M | 27.91%6.55M | -2.25%4.38M |
| Staff costs | 3.66%3.43M | 39.76%4.58M | 18.21%14.14M | 20.78%4.53M | 15.05%3.03M | 22.19%3.31M | 13.99%3.28M | 15.71%11.96M | 14.74%3.75M | 8.85%2.63M |
| Selling and administrative expenses | 1.77%460K | 44.12%490K | -2.85%1.69M | -28.19%461K | 0.46%436K | 35.74%452K | 3.34%340K | 24.58%1.74M | 15.84%642K | 35.63%434K |
| -Selling and marketing expense | 1.77%460K | 44.12%490K | -2.85%1.69M | -28.19%461K | 0.46%436K | 35.74%452K | 3.34%340K | 24.58%1.74M | 15.84%642K | 35.63%434K |
| Depreciation and amortization | 99.48%774K | 23.15%734K | 27.90%2.32M | 57.53%764K | 20.63%573K | -15.65%388K | 50.89%596K | 32.16%1.82M | 15.37%485K | 44.38%475K |
| -Depreciation | 99.48%774K | 23.15%734K | 27.90%2.32M | 57.53%764K | 20.63%573K | -15.65%388K | 50.89%596K | 32.16%1.82M | 15.37%485K | 44.38%475K |
| Other operating expenses | -7.98%1.31M | -7.57%1.26M | 3.95%5M | -25.70%1.25M | 19.80%1.3M | 6.97%1.43M | 73.03%1.36M | -10.57%4.81M | 113.62%1.68M | -26.56%1.08M |
| Total other operating income | -53.66%114K | ---- | ---- | ---- | -3.32%233K | 119.64%246K | ---- | ---- | ---- | 322.81%241K |
| Operating profit | 1.12%4.69M | 36.60%3.63M | 13.07%12.74M | -29.26%1.3M | 1.62%4.57M | 32.50%4.64M | 55.05%2.66M | 177.89%11.27M | 125.48%1.84M | 428.79%4.5M |
| Net non-operating interest income (expenses) | -100.00%-32K | 42.31%-15K | 49.12%-158.3K | -22.22%-44K | -13.11%-69K | 83.84%-16K | 77.39%-26K | 52.30%-311.12K | 77.39%-36K | 57.93%-61K |
| Non-operating interest expense | 100.00%32K | -42.31%15K | -49.12%158.3K | 22.22%44K | 13.11%69K | -83.84%16K | -77.39%26K | -52.30%311.12K | -77.39%36K | -57.93%61K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 62.96%-50K | -75K | 228.55%482.06K | 511.33%617K | 0 | -80.00%-135K | 0 | -375K | -150K | -75K |
| Less:Write off | -62.96%50K | --75K | -228.55%-482.06K | -511.33%-617K | --0 | 80.00%135K | --0 | --375K | --150K | --75K |
| Other non-operating income (expenses) | -12.34%135K | -3.96%618.02K | -69.42%37K | -36.10%154K | 17.86%643.48K | 121K | ||||
| Income before tax | 2.70%4.61M | 31.93%3.67M | 21.89%13.68M | 7.80%1.91M | 3.21%4.5M | 34.90%4.49M | 57.82%2.78M | 184.28%11.23M | 47.43%1.77M | 518.13%4.36M |
| Income tax | -1.34%1.1M | 85.40%1.26M | 8.21%3.35M | -15.26%422K | -0.62%1.13M | 22.83%1.12M | 23.50%678K | 108.35%3.09M | -18.39%498K | 548.00%1.13M |
| Net income | 4.04%3.51M | 14.72%2.42M | 27.10%10.34M | 16.82%1.49M | 4.55%3.38M | 39.45%3.37M | 73.33%2.11M | 230.02%8.13M | 115.46%1.27M | 508.29%3.23M |
| Net income continuous operations | 4.04%3.51M | 14.72%2.42M | 27.10%10.34M | 16.82%1.49M | 4.55%3.38M | 39.45%3.37M | 73.33%2.11M | 230.02%8.13M | 115.46%1.27M | 508.29%3.23M |
| Noncontrolling interests | -31K | -29.26K | -13K | 0 | 0 | 0 | ||||
| Net income attributable to the company | 4.04%3.51M | 16.19%2.45M | 27.46%10.37M | 17.85%1.5M | 4.55%3.38M | 39.45%3.37M | 73.33%2.11M | 230.02%8.13M | 115.46%1.27M | 508.29%3.23M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 4.04%3.51M | 16.19%2.45M | 27.46%10.37M | 17.85%1.5M | 4.55%3.38M | 39.45%3.37M | 73.33%2.11M | 230.02%8.13M | 115.46%1.27M | 508.29%3.23M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 4.76%0.0088 | 15.09%0.0061 | 27.59%0.0259 | 15.63%0.0037 | 4.94%0.0085 | 40.00%0.0084 | 76.67%0.0053 | 207.58%0.0203 | 128.57%0.0032 | 523.08%0.0081 |
| Diluted earnings per share | 4.94%0.0085 | 5.77%0.0055 | 13.79%0.0231 | 12.50%0.0036 | 1.23%0.0082 | 35.00%0.0081 | 73.33%0.0052 | 207.58%0.0203 | 128.57%0.0032 | 523.08%0.0081 |
| Dividend per share | 0 | 0.007 | 27.27%0.014 | 0.00%0.006 | 0.008 | 0 | 0 | 0.011 | 0.006 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.